These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29414687)

  • 41. Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses.
    Lee J; Moraes-Vieira PM; Castoldi A; Aryal P; Yee EU; Vickers C; Parnas O; Donaldson CJ; Saghatelian A; Kahn BB
    J Biol Chem; 2016 Oct; 291(42):22207-22217. PubMed ID: 27573241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mercaptoacetate blocks fatty acid-induced GLP-1 secretion in male rats by directly antagonizing GPR40 fatty acid receptors.
    Li AJ; Wang Q; Dinh TT; Simasko SM; Ritter S
    Am J Physiol Regul Integr Comp Physiol; 2016 Apr; 310(8):R724-32. PubMed ID: 26791830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.
    Hwang JS; Park JW; Nam MS; Cho H; Han IO
    Metabolism; 2015 Mar; 64(3):368-79. PubMed ID: 25516476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
    Lan H; Vassileva G; Corona A; Liu L; Baker H; Golovko A; Abbondanzo SJ; Hu W; Yang S; Ning Y; Del Vecchio RA; Poulet F; Laverty M; Gustafson EL; Hedrick JA; Kowalski TJ
    J Endocrinol; 2009 May; 201(2):219-30. PubMed ID: 19282326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes.
    Schultz Moreira AR; Rüschenbaum S; Schefczyk S; Hendgen-Cotta U; Rassaf T; Broering R; Hardtke-Wolenski M; Buitrago-Molina LE
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
    Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
    Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice.
    Du T; Yang L; Xu X; Shi X; Xu X; Lu J; Lv J; Huang X; Chen J; Wang H; Ye J; Hu L; Shen X
    J Endocrinol; 2019 Feb; 240(2):195-214. PubMed ID: 30400036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
    Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
    Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trans-11 vaccenic acid improves insulin secretion in models of type 2 diabetes in vivo and in vitro.
    Wang X; Gupta J; Kerslake M; Rayat G; Proctor SD; Chan CB
    Mol Nutr Food Res; 2016 Apr; 60(4):846-57. PubMed ID: 27061233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats.
    Zhang X; Yan G; Li Y; Zhu W; Wang H
    Biomed Pharmacother; 2010 Nov; 64(9):647-51. PubMed ID: 20888730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exercise training induces insulin-sensitizing PAHSAs in adipose tissue of elderly women.
    Brezinova M; Cajka T; Oseeva M; Stepan M; Dadova K; Rossmeislova L; Matous M; Siklova M; Rossmeisl M; Kuda O
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158576. PubMed ID: 31740387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice.
    Arora T; Wegmann U; Bobhate A; Lee YS; Greiner TU; Drucker DJ; Narbad A; Bäckhed F
    Mol Metab; 2016 Aug; 5(8):725-730. PubMed ID: 27656410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GPR40 is partially required for insulin secretion following activation of beta3-adrenergic receptors.
    Pang Z; Wu N; Zhang X; Avallone R; Croci T; Dressler H; Palejwala V; Ferrara P; Tocci MJ; Polites HG
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):18-25. PubMed ID: 20416356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic treatment with novel GPR40 agonists improve whole-body glucose metabolism based on the glucose-dependent insulin secretion.
    Tanaka H; Yoshida S; Oshima H; Minoura H; Negoro K; Yamazaki T; Sakuda S; Iwasaki F; Matsui T; Shibasaki M
    J Pharmacol Exp Ther; 2013 Sep; 346(3):443-52. PubMed ID: 23853170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
    Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
    Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of the Therapeutic Potential of New Antidiabetic Compounds Using Islet-on-a-Chip Microfluidic Model.
    Sokolowska P; Jastrzebska E; Dobrzyn A; Brzozka Z
    Biosensors (Basel); 2022 May; 12(5):. PubMed ID: 35624603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
    Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
    Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.